Superoxide dismutase (SOD) levels and fasting insulin (FINS) levels were significantly higher in NAFLD patients with higher BMP4 levels (P < 0.05). This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.